Emergent BioSolutions (EBS) Notes Payables (2016 - 2024)
Emergent BioSolutions (EBS) posted quarterly Notes Payables of $800000.0 for Q3 2024, down 99.81% year-over-year from $413.6 million in Q4 2023, and down 99.81% quarter-over-quarter from $415.2 million in Q2 2024.
Emergent BioSolutions (EBS) Notes Payables (2016 - 2024) Analysis & Trends
Emergent BioSolutions' Notes Payables history runs 8 years deep, the most recent figure standing at $800000.0 for Q3 2024.
- In Q3 2024, Notes Payables fell 99.81% year-over-year to $800000.0; the TTM figure through Sep 2024 stood at $800000.0 (down 99.81% YoY), while the FY2023 annual figure was $413.7 million, down 56.78% from the prior year.
- Notes Payables for Q3 2024 stood at $800000.0, down from $415.2 million in the prior quarter.
- The five-year high for Notes Payables was $957.3 million in Q4 2022, with the low at $800000.0 in Q3 2024.
- The 5-year median for Notes Payables is $31.6 million (2021), against an average of $231.0 million.
- The sharpest annual moves came in 2022 and 2024: Notes Payables surged 2929.43% in 2022, then sank 99.81% in 2024.
- Emergent BioSolutions' Notes Payables stood at $33.8 million in 2020, then slipped by 6.51% to $31.6 million in 2021, then soared by 2929.43% to $957.3 million in 2022, then tumbled by 56.78% to $413.7 million in 2023, then plunged by 99.81% to $800000.0 in 2024.
- Business Quant data shows EBS's Notes Payables at $800000.0 in Q3 2024, $415.2 million in Q2 2024, and $459.2 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.90 Bn | 40.24 Bn | 2.15 Bn |
| 3 | Zoetis | 32.51 Bn | 30.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.55 Bn | 683.80 Mn |
| 6 | Viatris | 18.97 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.17 Bn | 10.01 Bn | - |
| 10 | Emergent BioSolutions | 252.84 Mn | 111.94 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 415.20 Mn |
| Mar 31, 2024 | 459.20 Mn |
| Dec 31, 2023 | 413.70 Mn |
| Sep 30, 2023 | 413.60 Mn |
| Jun 30, 2023 | 455.20 Mn |
| Mar 31, 2023 | 950.70 Mn |
| Dec 31, 2022 | 957.30 Mn |
| Sep 30, 2022 | 21.20 Mn |
| Jun 30, 2022 | 31.60 Mn |
| Mar 31, 2022 | 31.60 Mn |
| Dec 31, 2021 | 31.60 Mn |
| Sep 30, 2021 | 31.60 Mn |
| Jun 30, 2021 | 28.80 Mn |
| Mar 31, 2021 | 26.00 Mn |
| Dec 31, 2020 | 33.80 Mn |
| Sep 30, 2020 | 30.90 Mn |
| Jun 30, 2020 | 29.10 Mn |
| Mar 31, 2020 | 26.30 Mn |
| Dec 31, 2019 | 12.90 Mn |